3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
6
Hematologic Neoplasms
5
Breast Neoplasms
4
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Glioma
3
Colorectal Neoplasms
3
Prostatic Neoplasms
2
Neoplasms by Site
2
Motor Activity
2
Head and Neck Neoplasms
2
Glioblastoma
2
Carcinoma, Transitional Cell
2
Anxiety Disorders
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uveal Melanoma
1
Uterine Neoplasms
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Interventions
Morphine
7
Fentanyl
5
Radiotherapy
4
Methadone
4
Zoledronic Acid
3
Tapentadol
2
Ropivacaine
2
Pregabalin
2
Prednisone
2
Ketamine
2
Ibandronic Acid
2
Hydromorphone
2
Glutamine
2
Cryotherapy
2
Cryosurgery
2
Bupivacaine
2
Acupuncture Therapy
2
Acetaminophen
2
pegfilgrastim
1
oxycodone naloxone combination
1
naloxegol
1
ixabepilone
1
incobotulinumtoxinA
1
imisopasem manganese
1
cyclobenzaprine
1
cabozantinib
1
acetaminophen, aspirin, caffeine drug combination
1
Zolpidem
1
Surveys and Questionnaires
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pain
×
Standard of Care
×
Clear all
NCT02867644
2022-12-20
HYCOREMA
Institut de Cancérologie de Lorraine
Phase NA
Terminated
171 enrolled